In Vivo Dynamic of Amyloid Induced Dystrophic Neurites

Robert Brendza, PhD
Washington University (St. Louis, MO)
Year Awarded:
2004
Grant Duration:
April 1, 2004 to March 31, 2006
Disease:
Alzheimer's Disease
Award Amount:
$100,000
Grant Reference ID:
A2004240
Award Type:
Standard
Award Region:
US Midwestern

In Vivo Dynamic of Amyloid Induced Dystrophic Neurites

Details


In AD, the appearance of dystrophic or degenerating neuritis, which are thought to disrupt neuronal function, correlates with the clinical severity of dementia. However, it remains unknown whether the damage to these neuronal structures is static, dynamic or possibly reversible. Dr. Brendza is analyzing neuritic plaques in the brains of living transgenic mice that develop amyloid plaques and AD-like pathology. Amyloid-associated dystrophic neurites, as well as unaffected neuron structures, can be visualized in these animals by their inherent fluorescence. Dr. Brendza is using this system to investigate whether dystrophic neurites undergo dynamic changes over time and to determine if treatments that remove amyloid will reverse the neuronal damage. It is hoped that this research will yield new insight into the dynamic nature of amyloid toxicity and help scientists understand whether removing existing amyloid or sequestering diffusible toxic forms of amyloid-beta peptide is a valid target for the treatment of Alzheimer's disease.

Publications

Brendza, R.P. and Holtzman, D.M. (2006) Amyloid-beta immunotherapies in mice and men. Alzheimer Dis. Assoc Disord. 20(2):118-123.  

Brendza, R.P., Bacskai, B.J., Cirrito, J.R., Simmons, K.A., Skoch, J.M., Klunk, W.E., Mathis, C.A., Bales, K.R., Paul, S.M., Hyman, B.T., and Holtzman, D.M. (2005) Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest. 115(2):428-433. [Alzforum Recommended Paper]  

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.